Current Position & Biography Daphne Koller is founder, CEO and a board member of insitro, a company applying machine learning to drug discovery and development. Her career connects academic AI research, online education and biotechnology. Her current company biography identifies her as a former Stanford computer-science professor who remains an adjunct faculty member, and as a former chief computing officer of Calico.
Koller also cofounded Coursera, where she previously served as co-CEO and president, and cofounded the digital learning platform Engageli. Those education ventures are part of her professional history, not a claim that she currently runs Coursera. Her academic training includes a Stanford computer-science doctorate and a master’s degree from the Hebrew University of Jerusalem.
Notable Contributions With Nir Friedman, Koller coauthored Probabilistic Graphical Models: Principles and Techniques, published by MIT Press in 2009. The book is a substantial reference on representing and reasoning about uncertainty through probabilistic models. It provides a concrete connection between her research career and the mathematical tools underlying machine learning, distinct from the commercial claims made by companies she has founded.
At insitro, the company describes its approach as combining large-scale biological data with machine learning to inform drug discovery. Its pipeline explanation emphasizes clinical data, cellular disease models and human genetics. These are descriptions of the company’s methods and ambitions. They do not, by themselves, establish that a candidate medicine is safe, effective or approved, or that AI has solved the challenges of drug development.
Business Context On 8 May 2025, STAT reported that insitro said it was reducing its staff by 22%, approximately 60 people. In the same report, a company spokesperson said the action would streamline operations, focus resources on key priorities and extend its runway into 2027. These are dated, attributed facts and the company’s stated explanation, not a current headcount or an independently verified guarantee of future financing. The reduction is relevant context for assessing how an AI-led discovery strategy translates into a sustainable research organization.
Why Katharos Is Following Them Koller’s work places AI in settings where success requires more than a compelling demonstration. Scientific models need evidence, educational systems need useful learning outcomes, and proposed medicines face demanding experimental and clinical tests. Her movement between those settings makes her relevant to understanding both the opportunities and practical constraints of applied AI.
Areas to Follow Track peer-reviewed findings, independently supported biological insights and clearly documented development milestones. Distinguish discovery-stage progress from clinical evidence, and follow changes in insitro’s research priorities and organizational strategy using dated reporting. In education, separate the history of platform-building from evidence about learning quality and access.
Reporting Scope Coverage should distinguish Koller’s personal research contributions from the collective work of coauthors, company employees and institutional partners. Company statements should remain attributed, and forecasts should not be presented as achieved outcomes. This profile is not medical or investment advice or an endorsement of any treatment or business. The United States is her primary professional market; Israel is an educational association. The photograph is archival and does not represent her current appearance.
Katharos Category Artificial Intelligence
Photo Credit Archival photograph: “The Future of Higher Education: Daphne Koller”, Mirko Ries / swiss-image.ch / World Economic Forum, Davos, 24 January 2013. CC BY-SA 2.0; cropped and resized; adaptation distributed under CC BY-SA 2.0. Source: https://commons.wikimedia.org/wiki/File:TheFutureofHigherEducationDaphneKoller_(8411917358).jpg ; original: https://www.flickr.com/photos/worldeconomicforum/8411917358/ ; license: https://creativecommons.org/licenses/by-sa/2.0/
